Shazia Hassan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Training AI to Simulate Reality Through Self-Constructed Representations

    by Rohan Shahane, Shazia Hassan, Nandita Giri, Sashi Kiran Kaata, Vijayakumar. Krishnapillai

    Generating correct and flexible models of realistic, partially unknown worlds is an old goal in artificial intelligence. Developments in representation learning, generative modelling, inventions of self-supervised methods mean that AI systems have attained inner models of the world that allow them to perform nearly the same as human perception regarding real-world dynamics without direct supervision. In this paper, an innovative training scheme to train AI agents to anticipate a reality by learning self-built portrayal of their environment is covered. Using variational autoencoders and generative adversarial networks, our method allows agents to learn underlying structure and predict future states and in addition to being able to represent a large number of complex realistic scenarios. We experimentally analyse the efficacy of this approach in the domains of synthetic and physical preparations that reinforce the realization of agents outfitted with self-built world models giving better generalization, predictive precision, and utilization of resources. With references to experimental results, the models are likely to contribute to increasing real-time decision making, autonomous control as well as creation of virtual environment in a wide selection of practical applications. Lastly, we mention some of the main limitations such as representation fidelity, scalability, and computational complexity and future directions depending on which simulations could be made to use better representations and achieve results that could be deployed in dynamic real-world environments more easily.

  • Cross-Domain DataOps with Federated Learning: Unlocking AI in Regulated and Consumer-Facing Systems

    by Gokul Narain Natarajan, Shazia Hassan, Raghavender Reddy Tuniki, Sana Zia Hassan

    The increasing pace of artificial intelligence (AI), its developments in domains like healthcare, finance and consumer applications require data solutions that can be robust, privacy oriented, and regulation ready. In this paper, a crossdomain framework, DataOps united with Federated Learning (FL), is presented to overcome the issues of distributed data governance, model accuracy and operational agility. Our solutions address the need by deploying DataOps to secure federated learning systems to allow the co-working of regulated institutions with front-end consumer systems, utilizing continuous integration, automated testing, and data pipeline orchestration. We introduce our new architecture which guarantees the data locality, compliance with the regulations of data privacy (e.g., GDPR, CA, HIPAA) as well as the adaptive updates to the models to respond to the new data sources (will be distributed across silos). Testing on heterogeneous data sets illustrates better training efficiency, reduced latency to convergence of a model and also a stable performance in situations they are deployed into. These are the implications of the study results; FL-enabled DataOps pipelines have the potential to revolutionize how to operationalize AI at scale with full respect of data sovereignty and consumer confidence.


  • Real-Time ML and LLM Optimization: Orchestrating Scalable Workflows in Distributed Commerce Environments

    by Karan Alang, Sana Zia Hassan, Venugopal Katkam, Shazia Hassan

    Due to the exponential increase of the data in the distributed commerce settings, new issues of the real-time decision making and operational scale have emerged. In order to solve these problems, this paper proposes an orchestration framework that brings together real-time machine learning (ML) models with large language models (LLMs) to optimize distributed workflows in e-commerce ecosystems. The suggested framework relies on micro services-based architecture, edgecloud synergy, and semantic data pipelines to enable low-latency inference, adaptive learning, and context-aware automation. With the integration of reinforcement learning to adapt dynamic workflows and intelligent task coordination and personalized customer interactions based on LLMs, the system provides efficiency in operations and enhanced user interaction. Evaluations on a real-world retail data set show, under varying load conditions, large latency reduction and throughput gains as well as high model accuracy. The scalability, fault tolerance and DataOps/MLOps pipeline integration are also studied, which makes the model applicable to enterprise-level deployment across multi-cloud setups.

  • Open Access

    Quantum as a Service (QaaS) in Drug and Clinical Development

    by Shazia Hassan, Awanish Pandey

    The integration of artificial intelligence (AI)within the framework of Industry 4.0 is revolutionizingmanufacturing and production processes, significantlyenhancing operational efficiency and productivity. Thispaper explores the transformative impact of AI-driventechnologies, including the Internet of Things (IoT),automation, and digital twins, which create virtual replicasof physical systems for real-time monitoring and processoptimization. We delve into the critical role of supplychain optimization, utilizing AI and machine learning torefine demand forecasting and inventory management,enabling agile responses to market fluctuations.Furthermore, the paper examines predictive maintenancestrategies that leverage AI to anticipate equipmentfailures, thereby reducing downtime and boostingproductivity. Additionally, we discuss the implementationof robotic process automation (RPA) to streamlinerepetitive tasks, freeing human resources for morestrategic initiatives. Collectively, these advancementsunderscore the profound implications of AI on industrytransformation, setting the stage for future innovationssuch as Quantum as a Service in drug discovery andclinical development. This comprehensive analysishighlights the necessity for industries to embrace thesetechnologies to remain competitive in an evolvinglandscape.

  • Open Access

    Quantum Technology Application in product Development for Sustainability

    by Shazia Hassan, Sanazia Hassan

    Advancements in quantum computing have the potential to revolutionize sustainable product design through the rapid and efficient processing of complex environmental, economic, and manufacturing data. This review examines a breadth of literature discussing the integration of quantum-inspired algorithms in lifecycle assessment (LCA) and circular economy optimization, revealing both opportunities and challenges in product development for sustainability. The study employs systematic literature review methods and critical case study analyses, providing insights into methodological frameworks, successful deployments, scalability issues, and prospective technological transformations.

  • Open Access

    Artificial Intelligence Applications in Sustainable Life Sciences: A Global Review of Recent Developments and Implementations (2020–2024)

    by Shazia Hassan

    In recent years, the rapid development of artificial intelligence (AI) has spurred significant advances across a range of disciplines, not least in the domain of sustainable life sciences. This research paper investigates implemented AI solutions in sustainable life sciences, examining their global applicability and effectiveness over the period 2020 to 2024. Through a systematic review of recent literature and detailed case study analyses, we present quantitative data on AI performance indicators and sustainability metrics, underlining the benefits and challenges associated with these novel applications. In this study, interdisciplinary perspectives—spanning computer science, environmental science, biotechnology, and ethics—are synthesized to provide a comprehensive understanding of how AI can drive sustainability in life sciences, improve operational efficiency, and support decision making in various regulated industries. Real-world implementations from developed nations are examined to present comparative analyses, and data visualizations are employed to illustrate the financial, environmental, and performance metrics achieved by these AI systems. Ethical considerations are addressed throughout the study to ensure that the integration of AI in sustainable life sciences complies with current societal and environmental norms. The paper concludes with actionable recommendations and a five-year projection regarding the technology adoption curve for AI solutions in sustainable life sciences.

  • Open Access

    Advancements in AI for Drug Discovery: Exploring Machine Learning in Molecular Modeling (2018-2023)

    by Shazia Hassan

    The pharmaceutical industry continues to face significant challenges in reducing costs and timelines associated with drug discovery and development. Artificial intelligence (AI), particularly machine learning (ML) applications in molecular modeling, has emerged as a transformative asset. This white paper reviews the technological advancements and challenges in applying AI to drug discovery over the past five years (2018–2023), emphasizing FDA-approved drugdevelopment processes. This paper provides a comprehensive comparative analysis of AI models, detailed case studies from leading pharmaceutical companies, and a discussion on the regulatory frameworks and compliance standards governing AI in pharmaceutical research. In this study, we investigate how molecular modeling accuracy rates have improved and identify key implementation challenges, including data quality, interpretability of results, and integration into existing research workflows. The discussion is tailored for pharmaceutical researchers with an intermediate grasp of machine learning concepts, aiming to bridge the gap between research and practical application.

  • Open Access

    Adoption of Blockchain Technology in Enhancing Supply Chain for Sustainable Practices: Case Study Review and Proposed Framework

    by Shazia Hassan

    The integration of blockchain technology into supply chain management presents a transformative opportunity to enhance sustainability practices across various industries. This paper explores the multifaceted benefits of adopting blockchain as a foundational framework for supply chains, emphasizing its potential to improve transparency, traceability, and accountability. By providing an immutable ledger, blockchain enables stakeholders to track the provenance of goods, ensuring ethical sourcing and reducing fraud. Additionally, the decentralized nature of blockchain fosters collaboration among supply chain participants, facilitating the sharing of critical information that can lead to more efficient resource utilization and waste reduction. Through case studies and empirical analysis, this paper illustrates how blockchain can mitigate environmental impacts, promote social responsibility, and ultimately drive sustainable practices within supply chains. The findings underscore the necessity for organizations to embrace this innovative technology as a critical component in their sustainability strategies, paving the way for a more resilient and responsible future in global commerce.


  • Open Access

    Advancement of Product Lifecycle Management in the Pharmaceutical Supply Chain: Streamlining Processes and Ensuring Regulatory Adherence in Product Lifecycle Management

    by Shazia Hassan

    The pharmaceutical supply chain faces increasing complexities due to stringent regulatory requirements, rapid technological advancements, and the need for enhanced collaboration among stakeholders. This paper explores the advancement of Product Lifecycle Management (PLM) within this critical sector, highlighting its role in optimizing processes from drug development through to market delivery. We analyze the integration of PLM systems with emerging technologies such as artificial intelligence, blockchain, and IoT, which facilitate real-time data sharing and decision-making. By employing case studies and industry insights, we illustrate how effective PLM strategies can lead to improved compliance, reduced time-to-market, and enhanced product quality. This research underscores the necessity for pharmaceutical companies to adopt robust PLM frameworks to navigate the evolving landscape and meet the demands of patients and healthcare providers effectively. Implementing these frameworks not only streamlines operations but also fosters innovation, enabling companies to respond swiftly to market changes and emerging health challenges. This adaptability is crucial in a sector where regulatory requirements and consumer expectations are constantly shifting, making it essential for companies to stay ahead of the curve. By leveraging advanced technologies such as artificial intelligence and data analytics, organizations can further optimize their PLM processes, ensuring they remain agile and competitive in a fast-paced environment.